NIH-funded research R21 grant

How bacteria control their ability to cause cholera

Official title: sRNA-regulated S-glutathionylation controls Vibrio cholerae virulence

Funded at University of Pennsylvania · NIH-10763882 · Data updated 2026-11-12

This study is looking at how the cholera-causing bacteria, Vibrio cholerae, manages to infect the small intestine, especially when faced with the body's defenses, and it aims to find new ways to fight cholera by understanding the role of tiny molecules called sRNAs in this process.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJanuary 15, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$200,925
NIH project number5R21AI175874-02
Project IDNIH-10763882 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals, particularly infants, who are at risk of cholera infection or have been diagnosed with cholera.

Less likely to help

Patients who do not have cholera or are not at risk of cholera infection may not benefit from this research.

What this research studies

This research investigates how the bacterium Vibrio cholerae, which causes cholera, regulates its ability to infect the small intestine. It focuses on small regulatory RNAs (sRNAs) that help the bacteria respond to stress from the host's immune system. By understanding how these sRNAs influence the bacteria's virulence through a process called S-glutathionylation, researchers aim to uncover new ways to combat cholera infections. The study uses laboratory techniques to analyze gene expression and bacterial behavior in response to oxidative stress.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cholera infections.

How similar studies have gone: Other research has shown success in understanding bacterial virulence mechanisms, making this approach promising but still innovative.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Zhu, Jun — University of Pennsylvania
  • Study coordinator: Zhu, Jun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.